NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said after the close of the market on Tuesday that it has completed the $2.1 billion purchase of chromatography firm Dionex through a short-form merger.
Today, Thermo Fisher also announced it has acquired Sterilin, a provider of single-use plastic products, for an undisclosed amount.
Pursuant to the terms of the Dionex merger, all shares of the company will be exchanged for $118.50 per share. Dionex's stock ceased trading on Nasdaq after the close of the market today, and will be delisted.
Thermo Fisher had completed the tender offer for Dionex last Friday, following clearance from the European Union.
Commenting on the Sterilin acquisition, Marc Casper, president and CEO of Thermo Fisher, said in a statement that it broadens the range of specialty laboratory products that the firm offers. The business will be integrated into Thermo Fisher's Laboratory Products and Services segment.
Based in South Wales, UK, Sterilin posted $35 million in revenues in 2010 and has about 270 employees. Its products serve the microbiology, life sciences, and clinical markets.